Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;19(6):374.
doi: 10.1038/d41573-020-00029-9.

GPR84: an immune response dial?

GPR84: an immune response dial?

Megan L Wojciechowicz et al. Nat Rev Drug Discov. 2020 Jun.
No abstract available

PubMed Disclaimer

Figures

Fig. 1 ∣
Fig. 1 ∣. Chemical tools to target GPR84 and their downstream effects.
Examples of agonists that activate the GPR84 receptor include embelin, 6-n-octylaminouracil (6-OAU), diindolylmethane, 2-(hexylthio)pyrimidine-4,6-diol (ZQ-16), 6-hexylamino-2,4(1H,3H)-pyrimidinedione (PSB-1584), and medium-chain fatty acids (9–14 carbons). GPR84 activation using the selective biased agonist DL-175 has been shown to lead to phagocytosis and a pro-inflammatory response. PBI-4050, an antagonist of GPR84 as well as an agonist of GPR40, reduced liver, pulmonary and kidney fibrosis in mouse and rat models.

References

    1. Montgomery MK et al. Regulation of mitochondrial metabolism in murine skeletal muscle by the medium-chain fatty acid receptor Gpr84. The FASEB Journal 33, 12264–12276, doi:10.1096/fj.201900234R (2019). - DOI - PMC - PubMed
    1. Suzuki M et al. Medium-chain Fatty Acid-sensing Receptor, GPR84, Is a Proinflammatory Receptor. Journal of Biological Chemistry 288, 10684–10691, doi:10.1074/jbc.M112.420042 (2013). - DOI - PMC - PubMed
    1. Köse M et al. An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights. Journal of Medicinal Chemistry 63, 2391–2410, doi:10.1021/acs.jmedchem.9b01339 (2020). - DOI - PubMed
    1. Lucy D et al. A Biased Agonist at Immunometabolic Receptor GPR84 Causes Distinct Functional Effects in Macrophages. ACS Chemical Biology 14, 2055–2064, doi:10.1021/acschembio.9b00533 (2019). - DOI - PubMed
    1. Gagnon L et al. A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84. The American Journal of Pathology 188, 1132–1148, doi:10.1016/j.ajpath.2018.01.009 (2018). - DOI - PubMed

MeSH terms

Substances